Citi assesses Keurig Dr Pepper’s risk from rising coffee prices

Investing.com
13 Feb

Investing.com -- Citi analysts weighed the risks facing Keurig Dr Pepper Inc (NASDAQ:KDP) as surging green coffee prices put pressure on the company's 2025 outlook.

Arabica coffee prices have climbed about 80% in the last six months, driven by weather-related supply disruptions in Brazil and tariff concerns. Despite these challenges, Citi remains Buy-rated on Keurig Dr Pepper on strength in its beverage businesses, which account majority of sales and profits.

Citi for its base case expects KDP to achieve mid-single-digit earnings per share growth in 2025, with U.S. coffee profits declining 8.5% year-over-year. The firm assumes green coffee costs make up 18% of KDP’s U.S. coffee cost of goods sold, rising about 70% from a year earlier, and that the company takes a weighted average 5% price increase.

Under a bear case scenario, where coffee costs represent 27% of U.S. coffee COGS and inflation reaches 90%, Citi sees coffee profits dropping 19% and flat EPS growth. A more optimistic outlook assumes lower cost exposure and stronger price increases, keeping EPS growth in the high single digits.

Related Articles

Citi assesses Keurig Dr Pepper’s risk from rising coffee prices

Republican senators call for $1,000 tax on new EV sales to pay for road repairs

JPMorgan assumes coverage of PG&E, Edison

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10